Global Cancer Drugs Market Analysis: Growth Drivers, Competitive Landscape, and Future Outlook (2025
The global cancer drugs market is projected to experience substantial growth in the coming years, driven by rising cancer prevalence, technological advancements in treatment, and increasing investments in oncology research. The market size is expected to reach US$ 516.15 billion by 2031, up from US$ 225.96 billion in 2024, registering a robust CAGR of 12.6% from 2025 to 2031. The growing burden of cancers such as breast and lung cancer, along with heightened awareness among populations and healthcare providers, has significantly contributed to the increasing adoption of cancer therapeutics worldwide.